|
|
|
Insider
Information: |
Schroeder Theodore R |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
22,996 |
|
Indirect Shares
|
117,489 |
|
|
Direct
Value |
$380,610 |
|
|
Indirect Value
|
$46,267 |
|
|
Total
Shares |
140,485 |
|
|
Total
Value |
$426,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-100.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cadence Pharmaceuticals Inc |
CADX |
President, CEO, Director |
2014-03-19 |
0 |
2014-03-19 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-08-13 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2020-05-20 |
11,007 |
2018-05-24 |
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
11,989 |
2019-08-27 |
117,489 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2014-03-19 |
4 |
D |
$14.00 |
$177,296 |
D/D |
(12,664) |
0 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2014-03-19 |
4 |
D |
$14.00 |
$4,305,000 |
I/I |
(307,500) |
0 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
Director |
|
2015-05-07 |
4 |
D |
$46.00 |
$28,382 |
D/D |
(617) |
0 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
Director |
|
2015-05-07 |
4 |
D |
$46.00 |
$141,818 |
D/D |
(3,083) |
0 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,253 |
2,253 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
Director |
|
2014-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
3,700 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,707 |
6,960 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,047 |
11,007 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2023-01-29 |
4 |
D |
$1.50 |
$647 |
D/D |
(431) |
11,989 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2023-01-06 |
4 |
D |
$1.30 |
$14 |
D/D |
(11) |
12,420 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-12-31 |
4 |
D |
$1.89 |
$9 |
D/D |
(5) |
12,431 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-12-06 |
4 |
D |
$2.02 |
$18 |
D/D |
(9) |
12,436 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-11-30 |
4 |
D |
$2.25 |
$11 |
D/D |
(5) |
12,445 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-11-06 |
4 |
D |
$2.24 |
$22 |
D/D |
(10) |
12,450 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-10-31 |
4 |
D |
$2.54 |
$13 |
D/D |
(5) |
12,460 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-10-06 |
4 |
D |
$2.72 |
$24 |
D/D |
(9) |
12,465 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-09-30 |
4 |
D |
$2.08 |
$10 |
D/D |
(5) |
12,474 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2011-11-02 |
4 |
D |
$5.72 |
$41,962 |
D/D |
(7,336) |
12,664 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2011-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2020-12-31 |
4 |
D |
$2.42 |
$293 |
D/D |
(121) |
64,518 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2019-07-25 |
4 |
A |
$0.00 |
$0 |
I/I |
6,748 |
67,489 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2019-08-27 |
4 |
B |
$1.79 |
$89,500 |
I/I |
50,000 |
117,489 |
2.66 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-09-06 |
4 |
D |
$1.11 |
$250 |
D/D |
(225) |
176,875 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-08-31 |
4 |
D |
$1.06 |
$113 |
D/D |
(107) |
177,100 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-08-06 |
4 |
D |
$1.17 |
$263 |
D/D |
(225) |
177,207 |
0 |
- |
|
90 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|